# A Study To Evaluate The Efficacy Of Eplerenone Compared With Losartan For The Treatment Of Patients With Mild To Moderate Hypertension

> **NCT00649311** · PHASE2 · TERMINATED · sponsor: **Pfizer** · enrollment: 248 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** eplerenone
- **DRUG:** Losartan

## Key facts

- **NCT ID:** NCT00649311
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-04
- **Primary completion:** —
- **Final completion:** 2003-09
- **Target enrollment:** 248 (ACTUAL)
- **Why stopped:** Poor enrollment; termination not due to safety reasons.
- **Last updated:** 2009-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00649311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00649311, "A Study To Evaluate The Efficacy Of Eplerenone Compared With Losartan For The Treatment Of Patients With Mild To Moderate Hypertension". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00649311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*